Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03757013
What this trial is testing

Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

Who this might be right for
Psoriasis
Amgen 453
Early research (Phase 1)Study completedNCT01510951
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 9
Testing effectiveness (Phase 2)Study completedNCT05364554
What this trial is testing

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 227
Large-scale testing (Phase 3)Study completedNCT00687401
What this trial is testing

Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 215
Testing effectiveness (Phase 2)Ended earlyNCT05655299
What this trial is testing

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Ventyx Biosciences, Inc 222
Testing effectiveness (Phase 2)Study completedNCT01107457
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 142
Large-scale testing (Phase 3)Study completedNCT03897075
What this trial is testing

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Nail Psoriasis
Sun Pharmaceutical Industries Limited 99
Testing effectiveness (Phase 2)Study completedNCT01987843
What this trial is testing

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tanabe Pharma Corporation 142
Large-scale testing (Phase 3)Study completedNCT00658788
What this trial is testing

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 305
Not applicableStudy completedNCT03236870
What this trial is testing

Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Who this might be right for
Psoriasis
AbbVie 181
Testing effectiveness (Phase 2)Study completedNCT01096862
What this trial is testing

Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Inc 124
Testing effectiveness (Phase 2)Study completedNCT01855880
What this trial is testing

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 54
Testing effectiveness (Phase 2)Study completedNCT01072383
What this trial is testing

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Biotest 49
Large-scale testing (Phase 3)Study completedNCT03766685
What this trial is testing

Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 172
Post-approval studies (Phase 4)Study completedNCT00249808
What this trial is testing

Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 1,266
Early research (Phase 1)Study completedNCT03718884
What this trial is testing

Mirikizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 29
Large-scale testing (Phase 3)Study completedNCT03073200
What this trial is testing

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 201
Large-scale testing (Phase 3)Study completedNCT03090100
What this trial is testing

Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 1,048
Not applicableNot Yet RecruitingNCT07190391
What this trial is testing

Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Daewoong Pharmaceutical Co. LTD. 425
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation